benign prostatic hyperplasia


Also found in: Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.

benign prostatic hyperplasia

n.
A nonmalignant enlargement of the prostate gland commonly occurring in men after the age of 50, and sometimes leading to compression of the urethra and obstruction of the flow of urine.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.benign prostatic hyperplasia - enlarged prostate; appears to be part of the natural aging process
hyperplasia - abnormal increase in number of cells
References in periodicals archive ?
Update on AUA guideline on the management of benign prostatic hyperplasia.
If you have symptoms of benign prostatic hyperplasia, "the first step should be to see a physician," advises urologist Glenn Gerber, an associate professor of surgery at the University of Chicago.
Enlargement of the prostate, or benign prostatic hyperplasia (BPH), is a common noncancerous disorder of men.
Additionally, Synaptic began making available non-exclusive licenses to its benign prostatic hyperplasia intellectual property estate for which Synaptic has been granted five additional United States patents and two foreign patents.
Complete report on H1 2015 pipeline review of Benign Prostatic Hyperplasia with 51 market data tables and 15 figures, spread across 133 pages is available at http://www.
Etiology, pathophysiology, epidemiology and natural history of benign prostatic hyperplasia.
Additionally, Synaptic began making available nonexclusive licenses to its benign prostatic hyperplasia intellectual property estate for which Synaptic has been granted an additional five United States patents and two foreign patents.
A snapshot of the global therapeutic scenario for Benign Prostatic Hyperplasia.
AUA Guidelines on management of benign prostatic hyperplasia (2003).
The ThermaStent is the second stent device developed for Endocare's benign prostatic hyperplasia product line.
com/research/gp6tkz/global_benign) has announced the addition of the "Global Benign Prostatic Hyperplasia Drug Pipeline Capsule - 2012 Update" report to their offering.
May 15, 2015 /PRNewswire/ -- PROCEPT BioRobotics, a clinical-stage medical device company, announced today the results of a Phase II study investigating the safety and feasibility of Aquablation, a minimally invasive water ablation therapy, for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (BPH).

Full browser ?